Literature DB >> 10902805

Expression of the pituitary transcription factor Ptx-1, but not that of the trans-activating factor prop-1, is reduced in human corticotroph adenomas and is associated with decreased alpha-subunit secretion.

R H Skelly1, M Korbonits, A Grossman, G M Besser, J P Monson, J F Geddes, J M Burrin.   

Abstract

We have studied the expression of the pituitary transcription factors Ptx-1 and Prop-1 in a series of 34 pituitary adenomas fully characterized for in vitro hormone secretion and histological staining. In studies involving mammalian cell lines, the pituitary transcription factor Ptx-1 has been shown to be a pituitary hormone panactivator, whereas more recent studies have shown that it plays an important role in alpha-subunit gene expression. Its expression has not been examined previously in human pituitary adenomas characterized by in vitro hormone secretory profiles. Of the 34 pituitary adenomas studied, Ptx-1 expression was reduced by more than 50% compared to that of the housekeeping gene human glyceraldehyde-3-phosphate dehydrogenase in the 6 corticotroph adenomas, which also had significantly reduced alpha-subunit production (all 6 tumors secreting < or =0.5 ng/24 h). Mutations of the pituitary transcription factor Prop-1, which is responsible for the syndrome of Ames dwarfism in mice, are being increasingly recognized as a cause of combined pituitary hormone deficiency in humans, although ACTH deficiency has been described only once. Prop-1 expression was detected in all 34 pituitary adenomas, including 6 corticotroph adenomas and 5 gonadotroph adenomas. The expression of Prop-1 has not been described previously in these cell phenotypes.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10902805     DOI: 10.1210/jcem.85.7.6683

Source DB:  PubMed          Journal:  J Clin Endocrinol Metab        ISSN: 0021-972X            Impact factor:   5.958


  4 in total

Review 1.  Genesis of pituitary adenomas: state of the art.

Authors:  G Faglia; A Spada
Journal:  J Neurooncol       Date:  2001-09       Impact factor: 4.130

2.  Silent corticogonadotroph adenomas: clinical and cellular characteristics and long-term outcomes.

Authors:  Odelia Cooper; Anat Ben-Shlomo; Vivien Bonert; Serguei Bannykh; James Mirocha; Shlomo Melmed
Journal:  Horm Cancer       Date:  2010-04       Impact factor: 3.869

3.  No mutations in TPIT, a corticotroph-specific gene, in human tumoral pituitary ACTH-secreting cells.

Authors:  L G Bucciarelli; F Pecori Giraldi; F Cavagnini
Journal:  J Endocrinol Invest       Date:  2005-12       Impact factor: 4.256

4.  Comparative genomics reveals functional transcriptional control sequences in the Prop1 gene.

Authors:  Robert D Ward; Shannon W Davis; Minchul Cho; Constance Esposito; Robert H Lyons; Jan-Fang Cheng; Edward M Rubin; Simon J Rhodes; Lori T Raetzman; Timothy P L Smith; Sally A Camper
Journal:  Mamm Genome       Date:  2007-06-08       Impact factor: 2.957

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.